Fresenius Kabi.
company based in Bad Homborg, Germany; offers health products for the critically and chronically ill.
- Reports this week
- 0
- Active events
- 0
- Connections
- 22
What's happening
Earlier this month
One to three months ago
Gone quiet
No new reports in 90+ days-
Fresenius Kabi received regulatory approvals from the EMA and FDA for a vedolizumab biosimilar, while excluding commercialization in the Middle East and North Africa.Some support1 report
-
Companies ICU Medical, Fresenius Kabi, Baxter, and Codan are noted as key players in a market where Germany holds the largest market share.Some support1 report
-
Fresenius Kabi acquired a majority stake in mAbxience, which subsequently received European Commission approval for its biosimilars.Speculative1 report
-
Fresenius Kabi received an award announcement in Lake Zurich, Illinois.Some support1 report
-
Fresenius Kabi is involved in shaping the future of healthcare across Southeast Asia.Some support1 report
-
Fresenius Kabi, Charles River Laboratories, Intertek, and Gea were listed in a market report profile.Some support1 report
-
Litigation over patents and generics is ongoing, and DOMA Perpetual Capital Management holds 7.5% of Pacira's outstanding shares.Some support2 reports
No events began in the chosen period. Widen it, or reset.
What's reaching Fresenius Kabi
Events traced to Fresenius Kabi, step by step, newest firstAround Fresenius Kabi this week
News at the entities that move Fresenius Kabi most-
European Medicines Agency TransactionalForbes reported on recent drug filings submitted to the FDA and the European Medicines Agency.Moves Fresenius Kabi
-
FDA StructuralFDA issued a warning letter to NeoGen regarding a product quality defect on October 7, 2026.Moves Fresenius Kabi
-
Morgan Stanley OperationalBaird lowered its price target for Nvidia, Morgan Stanley took it off its Top Pick list, and Jim Cramer predicted shares may not find a low.Moves Fresenius Kabi
-
Middle East OperationalAn MoU was signed to assist Filipino seafarers amidst ongoing geopolitical tensions.Moves Fresenius Kabi
-
Spain Shared contextInstacart commissioned market research studies in several European countries, including Italy and Spain.Moves Fresenius Kabi
-
North Africa TransactionalAllied nations are accelerating military procurement across North Africa, the Middle East, and Europe, involving RTX segments.Moves Fresenius Kabi
Connections
The 10 strongest of 22, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
European Medicines Agency Transactional
EMA accepted the Marketing Authorization Application (MAA) for the vedolizumab biosimilar product associated with Fresenius Kabi.
-
FDA Structural
The FDA granted regulatory approval for a vedolizumab biosimilar manufactured by Fresenius Kabi.
-
BioPharma Structural
Fresenius Kabi employs the President of BioPharma, indicating a formal organizational link.
-
Middle East Operational
Fresenius Kabi has excluded the Middle East from its commercialization rights.
-
Spain Shared context
The company maintains operational facilities in Spain as part of its European market presence.
-
Morgan Stanley Operational
Morgan Stanley has issued and reaffirmed an overweight rating on the shares of Fresenius Kabi.
-
North Africa Transactional
Fresenius Kabi has made a business decision to exclude North Africa from its commercialization rights.
-
Hall of Fame Transactional
Fresenius Kabi sponsors the Hall of Fame.
History
Events by the month they beganNovember 2026
1 eventOctober 2026
2 eventsAugust 2026
1 eventShow 2 earlier months
June 2026
6 events- Companies ICU Medical, Fresenius Kabi, Baxter, and Codan are noted as key players in a market where Germany holds the largest market share.
- Fresenius Kabi acquired a majority stake in mAbxience, which subsequently received European Commission approval for its biosimilars.
- Fresenius Kabi received an award announcement in Lake Zurich, Illinois.
- Fresenius Kabi is involved in shaping the future of healthcare across Southeast Asia.
- Fresenius Kabi, Charles River Laboratories, Intertek, and Gea were listed in a market report profile.
- Litigation over patents and generics is ongoing, and DOMA Perpetual Capital Management holds 7.5% of Pacira's outstanding shares.